NextCure NXTC Income Statement (2018-2026)

NASDAQ NXTC
$5.44 -0.23 (-4.06%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

NextCure Quarterly Income Statement

Periods 34 quarters
Latest Jun 2026

NextCure reported net income of -$15.09M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
Operating items
Research & DevelopmentR&D
13.60M12.26M15.02M12.83M13.53M12.82M11.65M13.45M11.01M11.83M11.40M12.42M8.77M8.90M7.90M24.09M6.14M6.80M6.83M7.43M
Selling, General & AdministrativeSG&A
4.91M4.81M5.75M5.30M5.71M4.95M5.42M5.71M4.61M3.96M4.36M4.08M3.73M3.55M3.73M3.20M2.81M2.96M3.27M2.59M
Restructuring CostsRestructuring
2.54M5.08M
Other Operating ExpensesOther Opex
0.34M0.50M0.37M0.38M0.31M0.32M0.29M0.33M0.41M0.32M
Operating ExpensesOpex
18.51M17.07M20.77M18.13M19.24M17.77M17.07M19.16M15.62M15.79M18.30M16.49M12.50M12.46M11.62M27.29M8.95M9.76M10.11M15.09M
Operating IncomeOp. Inc
-18.51M-17.07M-20.77M-18.13M-19.24M-17.77M-17.07M-19.16M-15.62M-15.79M-18.30M-16.49M-12.50M-12.46M-11.62M-27.29M-8.95M-9.76M-10.11M-15.09M
EBIT
-18.51M-17.07M-20.77M-18.13M-19.24M-17.77M-17.07M-19.16M-15.62M-15.79M-18.30M-16.49M-12.50M-12.46M-11.62M-27.29M-8.95M-9.76M-10.11M-15.09M
Non-operating items
Other Non Operating IncomeOther Non Op Inc.
0.58M0.13M0.17M0.21M0.33M0.47M0.98M1.30M1.32M1.32M1.20M1.09M0.96M0.85M0.65M0.48M0.32M0.32M0.31M0.20M
Net income details
EBT
-18.51M-17.07M-20.77M-18.13M-19.24M-17.77M-17.07M-19.16M-15.62M-15.79M-18.30M-16.49M-12.50M-12.46M-11.62M-27.29M-8.95M-9.76M-10.11M-15.09M
Profit After TaxPAT
-18.51M-17.07M-20.77M-18.13M-19.24M-17.77M-17.07M-19.16M-15.62M-15.79M-18.30M-16.49M-12.50M-12.46M-11.62M-27.29M-8.95M-9.76M-10.11M-15.09M
Income from Continuing OperationsIncome (Continuing)
-18.51M-17.07M-20.77M-18.13M-19.24M-17.77M-17.07M-19.16M-15.62M-15.79M-18.30M-16.49M-12.50M-12.46M-11.62M-27.29M-8.95M-9.76M-10.11M-15.09M
Consolidated Net IncomeConsol Net Inc.
-18.51M-17.07M-20.77M-18.13M-19.24M-17.77M-17.07M-19.16M-15.62M-15.79M-18.30M-16.49M-12.50M-12.46M-11.62M-27.29M-8.95M-9.76M-10.11M-15.09M
Income towards Parent CompanyParent Net Inc
-17.93M-16.94M-20.60M-17.92M-18.91M-17.30M-16.10M-17.86M-14.30M-14.47M-17.11M-15.40M-11.54M-11.60M-10.98M-26.81M-8.62M-9.44M-9.80M-14.89M
Net Income towards Common StockholdersNet Income
-17.93M-16.94M-20.60M-17.92M-18.91M-17.30M-16.10M-17.86M-14.30M-14.47M-17.11M-15.40M-11.54M-11.60M-10.98M-26.81M-8.62M-9.44M-9.80M-14.89M
Additional items
EPS (Basic)
-7.79-7.36-8.92-7.75-8.18-7.48-6.95-7.70-6.16-6.24-7.36-6.61-4.95-4.98-4.70-11.29-3.22-3.32-1.87-2.80
EPS (Diluted)
-7.79-7.36-8.92-7.75-8.18-7.48-6.95-7.70-6.16-6.24-7.36-6.61-4.95-4.98-4.70-11.29-3.22-3.32-1.87-2.80
Shares Outstanding
2.30M2.30M2.31M2.31M2.31M2.31M2.31M2.32M2.32M2.32M2.33M2.33M2.33M2.33M2.33M2.37M2.68M2.84M5.24M5.31M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.30M2.30M2.31M2.31M2.31M2.31M2.31M2.32M2.32M2.32M2.33M2.33M2.33M2.33M2.33M2.37M2.68M2.84M5.24M5.31M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.30M2.31M2.31M2.31M2.31M2.31M2.31M2.32M2.32M2.33M2.33M2.33M2.33M2.33M2.33M2.34M2.68M2.84M5.24M5.31M
EBITDA
-16.77M-15.91M-19.71M-17.09M-18.22M-16.76M-16.11M-18.20M-14.67M-14.95M-17.51M-15.79M-11.80M-11.75M-10.97M-26.66M-8.41M-9.38M-9.82M-14.82M

NextCure Income Statement API

Pull NextCure's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NXTC&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY